The increasing prevalence of haemophiliaROSENDAAL, F. R; BRIEL, E.Thrombosis and haemostasis. 1990, Vol 63, Num 1, pp 145-145, issn 0340-6245, 1 p.Article

Factor VIII and coronary heat diseaseROSENDAAL, F. R.European journal of epidemiology. 1992, Vol 8, pp 71-75, issn 0393-2990, SUP1Conference Paper

Risk factors for venous thrombotic diseaseROSENDAAL, F. R.Thrombosis and haemostasis. 1999, Vol 82, Num 2, pp 610-619, issn 0340-6245Article

Hemophilia treatment in historical perspective : a review of medical and social developmentsROSENDAAL, F. R; SMIT, C; BRIET, E et al.Annals of hematology (Print). 1991, Vol 62, Num 1, pp 5-15, issn 0939-5555, 11 p.Article

High risk of venous thrombosis in patients with pancreatic cancer : A cohort study of 202 patientsBLOM, J. W; OSANTO, S; ROSENDAAL, F. R et al.European journal of cancer (1990). 2006, Vol 42, Num 3, pp 410-414, issn 0959-8049, 5 p.Article

Oral anticoagulant treatment in patients with mechanical heart valves : how to reduce the risk of thromboembolic and bleeding complications : Oral anticoagulation: how intense and for how long?CANNEGIETER, S. C; TORN, M; ROSENDAAL, F. R et al.Journal of internal medicine. 1999, Vol 245, Num 4, pp 369-374, issn 0954-6820Article

Inhibitors in hemophilia A : are some products safer ?BRIËT, E; ROSENDAAL, F. R.Seminars in hematology. 1994, Vol 31, Num 2, pp 11-15, issn 0037-1963, SUP4Conference Paper

Incidence of inhibitor development in a group of young hemophilia A patients treated exclusively with lyophilized cryoprecipitatePEERLINCK, K; ROSENDAAL, F. R; VERMYLEN, J et al.Blood. 1993, Vol 81, Num 12, pp 3332-3335, issn 0006-4971Article

Thrombophilia screening: a matter of debateKAMPHUISEN, P. W; ROSENDAAL, F. R.Netherlands journal of medicine. 2004, Vol 62, Num 6, pp 180-187, issn 0300-2977, 8 p.Article

Oral anticoagulation for cerebral ischemia of arterial origin: High initial bleeding riskTORN, M; ALGRA, A; ROSENDAAL, F. R et al.Neurology. 2001, Vol 57, Num 11, pp 1993-1999, issn 0028-3878Article

Risk factors for venous thrombosis : Prevalence, risk, and interactionROSENDAAL, F. R.Seminars in hematology. 1997, Vol 34, Num 3, pp 171-187, issn 0037-1963Article

Decreased mortality of ischaemic heart disease among carriers of haemophiliaSRAMEK, A; KRIEK, M; ROSENDAAL, F. R et al.Lancet (British edition). 2003, Vol 362, Num 9381, pp 351-354, issn 0140-6736, 4 p.Article

Hormonal state rather than age influences cut-off values of protein S : Reevaluation of the thrombotic risk associated with protein S deficiencyLIBERTI, G; BERTINA, R. M; ROSENDAAL, F. R et al.Thrombosis and haemostasis. 1999, Vol 82, Num 3, pp 1093-1096, issn 0340-6245Article

Thrombosis in the young : Epidemiology and risk factors. A focus on venous thrombosisROSENDAAL, F. R.Thrombosis and haemostasis. 1997, Vol 78, Num 1, pp 1-6, issn 0340-6245Conference Paper

Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosisVAN TILBURG, N. H; ROSENDAAL, F. R; BERTINA, R. M et al.Blood. 2000, Vol 95, Num 9, pp 2855-2859, issn 0006-4971Article

The emergence of a new species : the professional meta-analyst. Comment. Authors' replyROSENDAAL, F. R; COOK, D. J; GUYATT, G. H et al.Journal of clinical epidemiology. 1994, Vol 47, Num 12, pp 1325-1332, issn 0895-4356, 7 p.Article

The pill and venous thromboembolism : a disarray of several layers of debate : Venous thromboembolism and the pillHELMERHORST, F. M; ROSENDAAL, F. R; VANDENBROUCKE, J. P et al.Human reproduction (Oxford. Print). 1998, Vol 13, Num 5, pp 1119-1120, issn 0268-1161Article

Increased soluble P-selectin levels following deep venous thrombosis: cause or effect?BLANN, A. D; NOTEBOOM, W. M. P; ROSENDAAL, F. R et al.British journal of haematology. 2000, Vol 108, Num 1, pp 191-193, issn 0007-1048Article

The WHO technical report on cardiovascular disease and steroid hormone contraception : state-of-the-artHELMERHORST, F. M; ROSENDAAL, F. R; VANDENBROUCKE, J. P et al.Human reproduction (Oxford. Print). 1998, Vol 13, Num 11, pp 2981-2983, issn 0268-1161Article

Minor events and the risk of deep venous thrombosisEEKHOFF, E. M. W; ROSENDAAL, F. R; VANDENBROUCKE, J. P et al.Thrombosis and haemostasis. 2000, Vol 83, Num 3, pp 408-411, issn 0340-6245Article

Female hormones and thrombosisROSENDAAL, F. R; HELMERHORST, F. M; VANDENBROUCKE, J. P et al.Arteriosclerosis, thrombosis, and vascular biology. 2002, Vol 22, Num 2, pp 201-210, issn 1079-5642Article

John Hageman's factor and deep-vein thrombosis : Leiden thrombophilia studyKOSTER, T; ROSENDAAL, F. R; BRIET, E et al.British journal of haematology. 1994, Vol 87, Num 2, pp 422-424, issn 0007-1048Article

A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosisDE VISSER, M. C. H; ROSENDAAL, F. R; BERTINA, R. M et al.Blood. 1999, Vol 93, Num 4, pp 1271-1276, issn 0006-4971Article

Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivorsWILLEMSE, P. M; BURGGRAAF, J; HAMDY, N. A. T et al.British journal of cancer. 2013, Vol 109, Num 1, pp 60-67, issn 0007-0920, 8 p.Article

Page / 7